Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
40.8M
-
Shares change
-
-9.45M
-
Total reported value, excl. options
-
$52M
-
Value change
-
-$11.2M
-
Put/Call ratio
-
2.13
-
Number of buys
-
62
-
Number of sells
-
-75
-
Price
-
$1.26
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q2 2025
168 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q2 2025.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.8M shares
of 92.2M outstanding shares and own 44.24% of the company stock.
Largest 10 shareholders include Pfizer Inc (4.69M shares), VANGUARD GROUP INC (4.09M shares), Kynam Capital Management, LP (3.07M shares), Schonfeld Strategic Advisors LLC (2.27M shares), BlackRock, Inc. (1.88M shares), MILLENNIUM MANAGEMENT LLC (1.55M shares), TWO SIGMA ADVISERS, LP (1.45M shares), PFM Health Sciences, LP (1.36M shares), DIMENSIONAL FUND ADVISORS LP (1.31M shares), and GEODE CAPITAL MANAGEMENT, LLC (981K shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.